Powerlifting athlete receives sanction
The Australian Sports Anti-Doping Authority (ASADA) today acknowledged the decision of Powerlifting Australia (PA) to impose a two-year ban on athlete Alex Vuong for the presence and use of prohibited substances.
Mr Vuong returned an Adverse Analytical Finding from an in-competition doping control test on 10 June 2018 at a PA event at City Strength Headquarters, in Marrickville, NSW.
His sample was analysed at the Australian Sports Drug Testing Laboratory, part of the National Measurement Institute, which detected the presence of 1,4-Dimethylpentylamine and Higenamine.
It was determined that on or before 10 June 2018, Mr Vuong used a Prohibited Substance, namely Higenamine.
1,4-Dimethylpentylamine is banned in-competition only under the S6 classification of Stimulants. The substance is similar in structure to 1,3-dimethylamylamine (DMAA), which can cause side effects including cerebral haemorrhage and heart attacks and has been linked to a number of deaths in Australia and overseas.
Higenamine is a S3 class Beta-2 Agonist (these type of substances allow lungs to take in more oxygen) and is prohibited in- and out-of-competition. However, as a cardiotonic, higenamine can increase heart rate, putting an athlete at an increased risk of arrhythmias and even death.
Mr Vuong is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 20 February 2021.